Una píldora anticonceptiva masculina no hormonal nueva es altamente efectiva en los ratones y podrían comenzar las pruebas en humanos en el 2022, según los investigadores.
Related Posts
FDA Expands Indication for Use of Abemaciclib With Early, High-Risk Breast Cancer
March 10, 2023
FRIDAY, March 10, 2023 (HealthDay News) -- Abemaciclib (Verzenio) with endocrine...
Polluted Air Means More Asthma Attacks for Urban Kids
January 6, 2023
FRIDAY, Jan. 6, 2023 (HealthDay News) -- Air pollution may trigger more asthma...
Higher Maternal Death Rates Among Black Women Tied to Racism, Sexism, U.N. Says
July 13, 2023
THURSDAY, July 13, 2023 (HealthDay News) -- Black women are more likely to die...
ADHD Drugs Won’t Raise Risk for Illicit Drug Use Later
July 12, 2023
WEDNESDAY, July 12, 2023 (HealthDay News) -- Teens who use stimulant medication...